tradingkey.logo

Check Cap Ltd

CHEK
1.610USD
0.0000.00%
종가 02/06, 16:00ET시세는 15분 지연됩니다
9.42M시가총액
손실P/E TTM

Check Cap Ltd

1.610
0.0000.00%

자세한 내용은 Check Cap Ltd 회사

Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.

Check Cap Ltd 정보

종목 코드 CHEK
회사 이름Check Cap Ltd
상장일Feb 19, 2015
CEOOvadia (Alex)
직원 수- -
유형Ordinary Share
회계 연도 종료Feb 19
주소29 Abba Hushi Ave.
도시
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Israel
우편 번호3009000
전화97248303401
웹사이트https://check-cap.com/
종목 코드 CHEK
상장일Feb 19, 2015
CEOOvadia (Alex)

Check Cap Ltd의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Dr. Yoav Kimchy, Ph.D.
Dr. Yoav Kimchy, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Alex Ovadia
Mr. Alex Ovadia
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Steven J. Hanley
Mr. Steven J. Hanley
Chairman of the Board
Chairman of the Board
--
--
Mr. Yuval Yanai
Mr. Yuval Yanai
Independent Director
Independent Director
--
--
Mr. XiangQian (XQ) Lin
Mr. XiangQian (XQ) Lin
Independent Director
Independent Director
--
--
Dr. Mary Jo Gorman, M.D.
Dr. Mary Jo Gorman, M.D.
Independent Director
Independent Director
--
--
Mr. Boaz Shpigelman
Mr. Boaz Shpigelman
Vice President - Research and Development
Vice President - Research and Development
--
--
Ms. Clara Ezed
Ms. Clara Ezed
Independent Director
Independent Director
--
--
Mr. Joshua (Shuki) Belkar
Mr. Joshua (Shuki) Belkar
Vice President - Operations
Vice President - Operations
--
--
Mr. Israel Hershko
Mr. Israel Hershko
Vice President - Quality Assurance and Regulatory Affairs
Vice President - Quality Assurance and Regulatory Affairs
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Yoav Kimchy, Ph.D.
Dr. Yoav Kimchy, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Alex Ovadia
Mr. Alex Ovadia
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Steven J. Hanley
Mr. Steven J. Hanley
Chairman of the Board
Chairman of the Board
--
--
Mr. Yuval Yanai
Mr. Yuval Yanai
Independent Director
Independent Director
--
--
Mr. XiangQian (XQ) Lin
Mr. XiangQian (XQ) Lin
Independent Director
Independent Director
--
--
Dr. Mary Jo Gorman, M.D.
Dr. Mary Jo Gorman, M.D.
Independent Director
Independent Director
--
--

수익 분석

기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.

주식 보유 통계

마지막 업데이트: Sat, Feb 7
마지막 업데이트: Sat, Feb 7
주주
주주 유형
주주
주주
비율
EquityLine Alternate Assets GP Inc
10.46%
Ramanathan (Vijay)
4.94%
Symetryx Corp
4.65%
BNP Paribas Securities Corp. North America
0.30%
Dimensional Fund Advisors, L.P.
0.12%
기타
79.53%
주주
주주
비율
EquityLine Alternate Assets GP Inc
10.46%
Ramanathan (Vijay)
4.94%
Symetryx Corp
4.65%
BNP Paribas Securities Corp. North America
0.30%
Dimensional Fund Advisors, L.P.
0.12%
기타
79.53%
주주 유형
주주
비율
Corporation
15.11%
Individual Investor
4.94%
Research Firm
0.41%
Investment Advisor/Hedge Fund
0.16%
Investment Advisor
0.11%
Bank and Trust
0.05%
기타
79.22%

기관 주식 보유

마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
31
46.22K
2.97%
--
2025Q3
31
46.22K
2.97%
-83.61K
2025Q2
30
129.91K
3.13%
+25.59K
2025Q1
31
104.32K
4.46%
-156.41K
2024Q4
32
147.67K
2.55%
+134.65K
2024Q3
33
13.02K
3.40%
+4.10K
2024Q2
36
9.37K
3.50%
-1.09K
2024Q1
41
13.66K
3.76%
-206.06K
2023Q4
43
68.48K
6.43%
+25.25K
2023Q3
45
28.34K
6.39%
+11.71K
더 보기

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
EquityLine Alternate Assets GP Inc
762.72K
10.46%
--
--
Dec 31, 2024
Ramanathan (Vijay)
360.00K
4.94%
--
--
Dec 31, 2024
Symetryx Corp
338.63K
4.65%
--
--
Dec 31, 2024
BNP Paribas Securities Corp. North America
21.64K
0.3%
+1.50K
+7.45%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
8.96K
0.12%
--
--
Sep 30, 2025
UBS Financial Services, Inc.
476.00
0.01%
-5.47K
-91.99%
Sep 30, 2025
Morgan Stanley & Co. LLC
6.30K
0.09%
+2.30K
+57.44%
Sep 30, 2025
National Bank of Canada
3.27K
0.04%
--
--
Sep 30, 2025
Geode Capital Management, L.L.C.
2.93K
0.04%
--
--
Nov 30, 2025
J.P. Morgan Securities LLC
1.50K
0.02%
-210.00
-12.28%
Sep 30, 2025
더 보기

관련 ETF

이름
비율
데이터 없음

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
Nov 23, 2022
Merger
20→1
Nov 23, 2022
Merger
20→1
Nov 23, 2022
Merger
20→1
Nov 23, 2022
Merger
20→1
날짜
배당락일
유형
비율
Nov 23, 2022
Merger
20→1
Nov 23, 2022
Merger
20→1
Nov 23, 2022
Merger
20→1
Nov 23, 2022
Merger
20→1
KeyAI